| The economic burden of overweight and obesity in Saudi Arabia JD Malkin, D Baid, RF Alsukait, T Alghaith, M Alluhidan, H Alabdulkarim, ... PLoS One 17 (3), e0264993, 2022 | 26 | 2022 |
| Digital Biomarker–Based Interventions: Systematic Review of Systematic Reviews H Motahari-Nezhad, H Al-Abdulkarim, M Fgaier, MM Abid, M Péntek, ... Journal of Medical Internet Research 24 (12), e41042, 2022 | 19 | 2022 |
| Overweight and obesity in Saudi Arabia: consequences and solutions M Alluhidan, R Alsukait, T Alghaith, M Shekar, C Herbst World Bank Publications, 2022 | 11 | 2022 |
| Challenges in applying pharmacoeconomics at the hospital level: Experts based approach N Ibrahim, A Altwoijri, H Alabdulkarim, F Alnajjar, M AlSaqa’aby Glob J Med Therap 1 (1), 1-4, 2019 | 11 | 2019 |
| Disease-related costs published in the Middle East and North Africa Region: systematic review and analysis of transferability Z Zrubka, M Péntek, L Mhanna, T Abu-Zahra, M Mahdi-Abid, M Fgaier, ... PharmacoEconomics 40 (6), 587-599, 2022 | 10 | 2022 |
| Obesity burden and impact of weight loss in Saudi Arabia: A modelling study SA Alqahtani, HA Al-Omar, A Alshehri, A Abanumay, H Alabdulkarim, ... Advances in Therapy 40 (3), 1114-1128, 2023 | 9 | 2023 |
| Fixed dose combinations: a formulary decision guide LCA Esba, C Yousef, S Ismail, M Halim, H Almodaimegh, ... Health Policy and Technology 10 (2), 100500, 2021 | 9 | 2021 |
| COVID-19 and Saudi Arabia public financing of prescription drugs: An opportunity for reform Y AlRuthia, SA Alrashed, B Balkhi, MS Aljamal, S Alsifri, AM Alrumaih, ... Health Policy and Technology 10 (1), 3-6, 2021 | 9 | 2021 |
| Informing a cost-effectiveness threshold for Saudi Arabia AH Al-Jedai, J Lomas, HY Almudaiheem, YSH Al-Ruthia, S Alghamdi, ... Journal of Medical Economics 26 (1), 128-138, 2023 | 8 | 2023 |
| Cancer Management in Saudi Arabia: Recommendations by the Saudi Oncology HeAlth Economics ExpeRt GrouP (SHARP) N Alkhudair, M Alshamrani, H Samarkandi, H Almodaheem, ... Saudi Pharmaceutical Journal 29 (2), 115-120, 2021 | 7 | 2021 |
| Pharmacy and therapeutics committee preparedness plan for COVID-19 LC Abu Esba, HA Al-Abdulkarim, A Alrushidan, M Al Harbi Global Journal on Quality and Safety in Healthcare 3 (2), 55-64, 2020 | 6 | 2020 |
| An institutional guide for formulary decisions of biosimilars S Ismail, L Abu Esba, M Khan, H Al-Abdulkarim, H Modimagh, C Yousef Hospital Pharmacy 58 (1), 38-48, 2023 | 5 | 2023 |
| Real-World Impact of Switching From Insulin Glargine (Lantus®) to Basaglar® and Potential Cost Saving in a Large Public Healthcare System in Saudi Arabia Y AlRuthia, OH Bahari, S Alghnam, AM Alrumaih, H Asiri, M Alshammari, ... Frontiers in Public Health 10, 852721, 2022 | 5 | 2022 |
| The impact of obesity in Saudi Arabia: healthcare resource use and costs associated with obesity-related complications HA Al-Omar, A Alshehri, A Abanumay, H Alabdulkarim, A Alrumaih, ... Advances in Therapy 40 (4), 1430-1443, 2023 | 4 | 2023 |
| Humanistic and economic burden of atopic dermatitis for adults and adolescents in the Middle East and Africa region B Elezbawy, AN Fasseeh, E Fouly, M Tannira, H Dalle, S Aderian, ... Dermatology and Therapy 13 (1), 131-146, 2023 | 4 | 2023 |
| Expert-based strategies to improve access to cancer therapeutics at the hospital level AR Jazieh, N Ibrahim, H Abdulkareem, F Maraiki, K Alsaleh, M Thill Global Journal on Quality and Safety in Healthcare 1 (1), 6-12, 2018 | 4 | 2018 |
| Cost-efficiency analysis of conversion to biosimilar filgrastim for supportive cancer care and resultant expanded access analysis to supportive care and early-stage HER2+ … CC Yousef, MA Khan, H Almodaimegh, M Alshamrani, M Al-Foheidi, ... Journal of Medical Economics 26 (1), 394-402, 2023 | 3 | 2023 |
| Demographic Characteristics and Status of Vaccinated Individuals with a History of COVID-19 Infection Pre-or Post-Vaccination: A Descriptive Study of a Nationally … Y AlRuthia, HF Al-Salloum, OA Almohammed, AS Alqahtani, ... Vaccines 10 (2), 323, 2022 | 3 | 2022 |
| A Step Toward the Development of the First National Multi-Criteria Decision Analysis Framework to Support Healthcare Decision Making in Saudi Arabia A Al-Jedai, H Almudaiheem, Y Alruthia, A Althemery, H Alabdulkarim, ... Value in Health Regional Issues 41, 100-107, 2024 | 2 | 2024 |
| The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia B Elezbawy, AN Fasseeh, E Fouly, LCA Esba, H Al Abdulkarim, ... Journal of Medical Economics 25 (1), 1231-1239, 2022 | 2 | 2022 |
Mohammed AlluhidanSaudi Health Council在 shc.gov.sa 的电子邮件经过验证
